8-K GT Biopharma, Inc. 2026-09-03: filing_form_type
| Value | {"value": "8-K"} |
|---|---|
| Period | (as of 2026-09-03) |
| Status | current |
| Entity | 8-K GT Biopharma, Inc. 2026-09-03 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
Retrieved: 2026-09-03T17:59:09.377307+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/d953a07a-b58b-4f59-9f2b-3b833e8d9380
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
https://www.sec.gov/Archives/edgar/data/109657/000149315226041333/0001493152-26-041333-index.htmRetrieved: 2026-09-03T17:59:09.377307+02:00
Raw response sha256:
d158427e25321b86f24983dd665c0751…Cite as: FACTANKER, https://factanker.com/fact/d953a07a-b58b-4f59-9f2b-3b833e8d9380
History
- no predecessors — first report